Alterations in the dopaminergic receptor system after chronic administration of cocaine

Citations Over TimeTop 11% of 1993 papers

Abstract

Several studies suggest that one of the most important factors contributing to cocaine dependence is an alteration in the actions of the neurotransmitter dopamine in the central nervous system. In order to understand some of the neuroreceptor consequences of cocaine administration, groups of rats were injected with cocaine (2 daily doses of 15 mg/kg) for 1 to 21 days. Binding of [3H]cocaine, [3H]SCH23390, [3H]raclopride, and [3H]BTCP in striatal and cortical tissue from the treated animals was compared to controls. [3H]Cocaine binding was increased by the drug in the striatum and cortex at days 14 and 21, respectively. The binding of [3H]SCH23390 to D1 dopamine receptors was significantly increased at day 3 of cocaine exposure. In striatal membranes, [3H]BTCP binding to dopamine uptake sites was significantly increased after day 7, whereas binding in cortical membranes was increased from day 1. [3H]Raclopride binding to D2 dopamine receptors remained unchanged throughout the study in both cortical and striatal tissues. These results indicate that repeated exposure to cocaine produces an upregulation (possible supersensitivity) in cortical D1, cocaine, and DA-uptake sites which occurs in a time-dependent manner. These increases are coupled with an upregulation in striatal D1, cocaine, and DA-uptake sites, without simultaneous changes in D2 receptors. Thus, cocaine's effects are not uniformly distributed across all brain regions, but rather are focused within areas of the dopamine system.

Related Papers

• → Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence(1994)272 cited
• → Measuring age-related changes in dopamine D2 receptors with 11C-raclopride and 18F-N-methylspiroperidol(1996)139 cited
• → Cocaine-induced locomotor activity and cocaine discrimination in dopamine D2 receptor mutant mice(2002)62 cited
• → Mapping the landscape of human dopamine D2/3 receptors with [11C]raclopride(2019)39 cited
• → Challenges in the development of dopamine D2‐ and D3‐selective radiotracers for PET imaging studies(2017)33 cited